Annovis Bio, Inc. (ANVS) research: valuation against peers, fundamentals over time, risk and news coverage
ANVS
Annovis Bio, Inc.No data in this window.
Every report in our own archive tagged with this symbol, newest first — fetched from the archive alongside the market data.
- BREAKING STORYBEARISHCanaccord Cuts Crypto-Adjacent Targets as Digital Asset Headwinds Bite
Canaccord lowered price targets on Bullish, citing crypto headwinds, and on SharpLink Gaming on valuation grounds — a coordinated de-rating of digital-asset proxies. Separately, Paramount is seeking a $1.88 billion bond in the Warner Bros. merger antitrust litigation and Endeavour Mining fell sharply, underscoring event-driven dispersion beneath a calm index surface.
Every figure on this page is fetched and computed in your browser from free public sources — end-of-day prices and reported financials from Yahoo Finance's open endpoints, and our own archive for the coverage panel. Fundamental history on the free tier runs about four fiscal years and five quarters. Data is best-effort and unaudited; this is market research, not investment advice.